Annual ROE
279.31%
+1220.70%+129.67%
December 31, 2023
Summary
- As of February 7, 2025, CDTX annual return on equity is 279.31%, with the most recent change of +1220.70% (+129.67%) on December 31, 2023.
- During the last 3 years, CDTX annual ROE has risen by +576.37% (+194.02%).
- CDTX annual ROE is now at all-time high.
Performance
CDTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-218.94%
+224.43%+50.62%
September 30, 2024
Summary
- As of February 7, 2025, CDTX quarterly return on equity is -218.94%, with the most recent change of +224.43% (+50.62%) on September 30, 2024.
- Over the past year, CDTX quarterly ROE has increased by +195.86% (+47.22%).
- CDTX quarterly ROE is now -276.94% below its all-time high of 123.74%, reached on March 31, 2015.
Performance
CDTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CDTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +129.7% | +47.2% |
| 3 y3 years | +194.0% | +34.2% |
| 5 y5 years | +379.9% | +34.2% |
CDTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.7% | at high | +82.8% |
| 5 y | 5-year | at high | +129.7% | -141.4% | +82.8% |
| alltime | all time | at high | +129.7% | -276.9% | +82.8% |
Cidara Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -218.94%(-50.6%) |
| Jun 2024 | - | -443.37%(-40.6%) |
| Mar 2024 | - | -746.33%(+79.9%) |
| Dec 2023 | 279.31%(-129.7%) | -414.80%(+1.0%) |
| Sep 2023 | - | -410.53%(+85.6%) |
| Jun 2023 | - | -221.22%(-33.5%) |
| Mar 2023 | - | -332.85%(-73.8%) |
| Dec 2022 | -941.39%(+257.9%) | -1272.31%(+102.8%) |
| Sep 2022 | - | -627.41%(-37.2%) |
| Jun 2022 | - | -998.28%(+102.5%) |
| Mar 2022 | - | -493.07%(+13.3%) |
| Dec 2021 | -263.05%(-11.4%) | -435.01%(+4.5%) |
| Sep 2021 | - | -416.42%(+76.5%) |
| Jun 2021 | - | -235.88%(-14.6%) |
| Mar 2021 | - | -276.34%(+32.8%) |
| Dec 2020 | -297.06%(+250.5%) | -208.16%(+36.5%) |
| Sep 2020 | - | -152.52%(+48.7%) |
| Jun 2020 | - | -102.56%(+13.1%) |
| Mar 2020 | - | -90.69%(-10.4%) |
| Dec 2019 | -84.75% | -101.19%(+18.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -85.79%(-21.7%) |
| Jun 2019 | - | -109.56%(+18.8%) |
| Mar 2019 | - | -92.25%(+2.4%) |
| Dec 2018 | -99.79%(+7.0%) | -90.06%(-1.6%) |
| Sep 2018 | - | -91.50%(-5.2%) |
| Jun 2018 | - | -96.54%(-9.1%) |
| Mar 2018 | - | -106.21%(+18.0%) |
| Dec 2017 | -93.28%(+70.8%) | -90.04%(+9.6%) |
| Sep 2017 | - | -82.16%(+8.5%) |
| Jun 2017 | - | -75.72%(+18.1%) |
| Mar 2017 | - | -64.14%(+13.8%) |
| Dec 2016 | -54.62%(+76.3%) | -56.34%(+15.5%) |
| Sep 2016 | - | -48.80%(+19.2%) |
| Jun 2016 | - | -40.95%(+25.6%) |
| Mar 2016 | - | -32.60%(-19.0%) |
| Dec 2015 | -30.98%(-129.8%) | -40.26%(-23.7%) |
| Sep 2015 | - | -52.76%(-23.5%) |
| Jun 2015 | - | -68.95%(-155.7%) |
| Mar 2015 | - | 123.74%(+19.1%) |
| Dec 2014 | 103.92%(+8.1%) | 103.92% |
| Dec 2013 | 96.14% | - |
FAQ
- What is Cidara Therapeutics annual return on equity?
- What is the all time high annual ROE for Cidara Therapeutics?
- What is Cidara Therapeutics annual ROE year-on-year change?
- What is Cidara Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly ROE year-on-year change?
What is Cidara Therapeutics annual return on equity?
The current annual ROE of CDTX is 279.31%
What is the all time high annual ROE for Cidara Therapeutics?
Cidara Therapeutics all-time high annual return on equity is 279.31%
What is Cidara Therapeutics annual ROE year-on-year change?
Over the past year, CDTX annual return on equity has changed by +1220.70% (+129.67%)
What is Cidara Therapeutics quarterly return on equity?
The current quarterly ROE of CDTX is -218.94%
What is the all time high quarterly ROE for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly return on equity is 123.74%
What is Cidara Therapeutics quarterly ROE year-on-year change?
Over the past year, CDTX quarterly return on equity has changed by +195.86% (+47.22%)